Prosecution Insights
Last updated: October 04, 2026

K&L Gates LLP - Gambro

Technology area: Chemistry & Materials

11 pending office actions • 2 clients • 11 examiners • 5 art units • 0 of 11 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Analysis

K&L Gates LLP - Gambro operates in Chemistry & Materials. It has 34213 career applications. The firm has a resolved allowance rate of 84.55 percent. It averages 3.82 office actions per allowance. There are 8 pending office actions.

The 84.55 percent allowance rate is calculated from 34213 career applications. The average of 3.82 office actions per allowance shows the prosecution efficiency for allowed cases. The 8 pending office actions represent the current active docket in chemistry.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=34213 apps, methodology: how we score firms)

84.6%
Allowance Rate
n=34213
+0.65σ
Allowance Rate (norm)
n=34213
3.8
OAs to Allowance
n=20667
+0.03σ
OAs to Allow (norm)
n=20667
1082 days
Time to Allowance
n=20667
+8.9pp
Interview Lift
n=34213
32.5%
RCE Rate
n=34213
2.7%
Appeal Rate
n=34213

Rejection Performance (% of received rejections ultimately overcome)

76.2%
§101 Overcome
n=2437
77.2%
§102 Overcome
n=9011
77.9%
§103 Overcome
n=15242
77.9%
§112 Overcome
n=10440

Specialization & Scale

A61K, H01M, G06F
Top CPC Subclasses
13%
Top-3 CPC Share
n=34213
90
Practitioners
n=34213
380.1
Apps / Practitioner
n=34213

Portfolio Summary

11
Total Pending OAs
6
Non-Final OAs
4
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (45%)
4
Medium (36%)
2
Easy (18%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (9%)
§101 + other1 (9%)
§103 only2 (18%)
§102 only1 (9%)
§112 only2 (18%)
Double-patenting + other1 (9%)
Multi-statute (no §101)3 (27%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
45% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
18% of docket
4
Business / Other
36% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SPAMER, DONALD R 1 59.2% +32.1%
LUCCHESI, NICHOLAS D 1 78.4% +9.4%
BARSKY, JARED 1 50.2% +22.7%
STIGELL, THEODORE J 1 78.3% +14.9%
OSINSKI, BRADLEY JAMES 1 78.5% +11.3%
KURTZ, BENJAMIN M 1 56.8% +17.6%
FITZSIMMONS, ALLISON G 1 47.9% +16.1%
MCGANN, BERNADETTE KAREN 1 64.6% +20.3%
NEWTON, CHAD A 1 37.6% +23.2%
PEO, JONATHAN M 1 48.2% +48.1%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18030116 ESTIMATING RESIDUAL RENAL FUNCTION NEWTON, CHAD A 29d
18711827 DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER BARSKY, JARED —
18709360 PERITONEAL DIALYSIS SYSTEM HAVING A CAPILLARY PATIENT LINE FILTER STIGELL, THEODORE J —
18572121 ACIDIC AND ALKALINE CLEANING OF ION EXCHANGE SYSTEMS, SUCH AS WATER PURIFIERS, BY ION EXCHANGE RESIN FITZSIMMONS, ALLISON G —
18554418 APPARATUS AND METHODS FOR EFFICIENT PRODUCTION OF DIALYSIS FLUID USING FORWARD OSMOSIS MCGANN, BERNADETTE KAREN —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18030116 ESTIMATING RESIDUAL RENAL FUNCTION NEWTON, CHAD A 29d
18872148 DEVICE FOR DISINFECTING AND CLEANING A CATHETER, AND A METHOD THEREOF SPAMER, DONALD R —
18711827 DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER BARSKY, JARED —
18709360 PERITONEAL DIALYSIS SYSTEM HAVING A CAPILLARY PATIENT LINE FILTER STIGELL, THEODORE J —
18612526 SYSTEMS AND METHODS FOR PERITONEAL DIALYSIS HAVING POINT OF USE DIALYSIS FLUID PREPARATION INCLUDING MIXING AND HEATING THEREFORE OSINSKI, BRADLEY JAMES —
18608304 PREPARING AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS KURTZ, BENJAMIN M —
18572121 ACIDIC AND ALKALINE CLEANING OF ION EXCHANGE SYSTEMS, SUCH AS WATER PURIFIERS, BY ION EXCHANGE RESIN FITZSIMMONS, ALLISON G —
18554418 APPARATUS AND METHODS FOR EFFICIENT PRODUCTION OF DIALYSIS FLUID USING FORWARD OSMOSIS MCGANN, BERNADETTE KAREN —

Client Portfolio (2 clients)

Client (Assignee)Pending OAs
Baxter 10
Baxter Healthcare S.A. 1

Top Art Units

Art UnitApps
17792
17732
17991
36811
37811

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18872148 DEVICE FOR DISINFECTING AND CLEANING A CATHETER, AND A METHOD THEREOF Gambro Lundia AB SPAMER, DONALD R 1799 §112 Non-Final OA — Pending Dec 05, 2024
18844270 GENERATING MEDICAL FLUID FOR RENAL REPLACEMENT THERAPY Gambro Lundia AB LUCCHESI, NICHOLAS D §112 Non-Final OA — Pending Sep 05, 2024
18711827 DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER Gambro Lundia AB BARSKY, JARED §101§103 Final Rejection — Pending May 20, 2024
18709360 PERITONEAL DIALYSIS SYSTEM HAVING A CAPILLARY PATIENT LINE FILTER BAXTER HEALTHCARE SA STIGELL, THEODORE J §102§103 Non-Final OA — Pending May 10, 2024
18612526 SYSTEMS AND METHODS FOR PERITONEAL DIALYSIS HAVING POINT OF USE DIALYSIS FLUID PREPARATION INCLUDING MIXING AND HEATING THEREFORE Gambro Lundia AB OSINSKI, BRADLEY JAMES §102§103DP Non-Final OA — Pending Mar 21, 2024
18608304 PREPARING AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS Gambro Lundia AB KURTZ, BENJAMIN M 1779 §102 Final Rejection — Pending Mar 18, 2024
18572121 ACIDIC AND ALKALINE CLEANING OF ION EXCHANGE SYSTEMS, SUCH AS WATER PURIFIERS, BY ION EXCHANGE RESIN Gambro Lundia AB FITZSIMMONS, ALLISON G 1773 §102§103§112 Non-Final OA — Pending Dec 19, 2023
18554418 APPARATUS AND METHODS FOR EFFICIENT PRODUCTION OF DIALYSIS FLUID USING FORWARD OSMOSIS Gambro Lundia AB MCGANN, BERNADETTE KAREN 1773 §103§112 Final Rejection — Pending Oct 06, 2023
18030116 ESTIMATING RESIDUAL RENAL FUNCTION Gambro Lundia AB NEWTON, CHAD A 3681 §101 Non-Final OA 29d Pending Apr 04, 2023
18108091 PACKAGE FOR AN ACIDIC DIALYSIS FLUID CONCENTRATE CONTAINING CITRATE AND GLUCOSE Gambro Lundia AB PEO, JONATHAN M 1779 §103 Non-Final OA — Pending Feb 10, 2023
17634855 NON-REMOVABLE CONNECTION SYSTEM Gambro Lundia AB LE, QUYNH DAO 3781 §103 Final Rejection — Pending Feb 11, 2022

Managing K&L Gates LLP - Gambro's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month